The Outcomes of NRICM101 on SARS-COV-2 (COVID-19) Infection
1 other identifier
observational
51,000
1 country
1
Brief Summary
Traditional Chinese medicine is regarded as a dietary supplement in many countries around the world. Dietary supplement, NRICM101, has been available for people who diagnosed, suspected or prevented for coronavirus disease 2019 (COVID-19) in September 2020. It is expected to help people not to progress to severe illness, and reduce lung damage and mortality. The investigators gather the effects of people who taking NRICM101 using the Real-World Big Data Study and the network feedback information collection model. This study can be used as a reference for global prevention and control of coronavirus disease 2019 (COVID-19).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 4, 2020
CompletedFirst Posted
Study publicly available on registry
December 11, 2020
CompletedStudy Start
First participant enrolled
December 23, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedJanuary 13, 2021
January 1, 2021
2 years
December 4, 2020
January 11, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
negative of COVID-19 test
receive COVID 19 test and the result is negative
1 day to 2 months
free of COVID 19 disease symptoms and signs
free of COVID 19 disease symptoms and signs after took NRICM101
1 day to 2 months
Study Arms (1)
NRICM101
Subjects who confirmed, suspected or prevented infected of COVID 19 disease and received dietary supplement NRICM101
Interventions
Direction: Take 1 sachet 2-4 times daily directly or with 400cc water before or between meals Indication: Externally contracted seasonal epidemic Function: Relieving Exterior and Facilitating Lung, clear heat of lung, Wide chest and resolve phlegm
Eligibility Criteria
Subjects who confirmed, suspected or prevented infected of COVID 19 disease and take dietary supplement NRICM101
You may qualify if:
- Subjects who confirmed, suspected or prevented infected of COVID 19 disease and take dietary supplement NRICM101
You may not qualify if:
- Those who refuse to participate in observational research.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Research Institute of Chinese Medicine, Ministry of Health and Welfare
Taipei, 11221, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yi-Chang Su, MD, PhD
National Research Institute of Chinese Medicine, Ministry of Health and Welfare
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 4, 2020
First Posted
December 11, 2020
Study Start
December 23, 2020
Primary Completion
December 31, 2022
Study Completion
December 31, 2022
Last Updated
January 13, 2021
Record last verified: 2021-01